Interactions between glycopeptides and β-lactams against isogenic pairs of teicoplanin-susceptible and -resistant strains of Staphylxococcus haemolyticus

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 7, 2006, Pages 2577-2582

  Vignaroli, Carla ^a   Biavasco, Francesca ^a   Varaldo, Pietro E ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BETA LACTAM; GLYCOPEPTIDE; OXACILLIN; PENICILLIN G; TEICOPLANIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUTOLYSIS; BACTERIAL STRAIN; DRUG POTENTIATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS HAEMOLYTICUS;

ANTI-BACTERIAL AGENTS; BETA-LACTAMS; DRUG INTERACTIONS; DRUG RESISTANCE, BACTERIAL; GLYCOPEPTIDES; HUMANS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS HAEMOLYTICUS; TEICOPLANIN;

EID: 33745595906     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00260-06     Document Type: Article

References (33)

1. Aritaka, N., H. Hanaki, L. Cui, and K. Hiramatsu. 2001. Combination effect of vancomycin and β-lactams against a Staphylococcus aureus strain, Mu3, with heterogeneous resistance to vancomycin. Antimicrob. Agents Chemother. 45:1292-1294.
2. Bannerman, T. L. 2003. Staphylococcus, Micrococcus, and other catalase-positive cocci that grow aerobically, p. 384-404. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. A. Pfaller, and R. H. Yolken (ed.), Manual of clinical microbiology, 8th ed. American Society for Microbiology, Washington, D.C.
3. Barr, J. G., E. T. Smyth, and G. M. Hogg. 1990. In vitro antimicrobial activity of imipenem in combination with vancomycin or teicoplanin against Staphylococcus aureus and Staphylococcus epidermidis. Eur. J. Clin. Microbiol. Infect. Dis. 9:804-809.
4. Biavasco, F., E. Giovanetti, M. P. Montanari, R. Lupidi, and P. E. Varaldo. 1991. Development of in-vitro resistance to glycopeptide antibiotics: assessment in staphylococci of different species. J. Antimicrob. Chemother. 27:71-79.
5. Biavasco, F., C. Vignaroli, R. Lazzarini, and P. E. Varaldo. 2000. Glycopeptide susceptibility profiles of Staphylococcus haemolyticus bloodstream isolates. Antimicrob. Agents Chemother. 44:3122-3126.
6. Biavasco, F., C. Vignaroli, and P. E. Varaldo. 2000. Glycopeptide resistance in coagulase-negative staphylococci. Eur. J. Clin. Microbiol. Infect. Dis. 19:403-417.
7. Billot-Klein, D., L. Gutmann, D. Bryant, D. Bell, J. van Heijenoort, J. Grewal, and D. M. Shlaes. 1996. Peptidoglycan synthesis and structure in Staphylococcus haemolyticus expressing increasing levels of resistance to glycopeptide antibiotics. J. Bacteriol. 178:4696-4703.
8. Blumenthal, R. M., R. Raeder, C. D. Takemoto, and E. H. Freimer. 1983. Occurrence and expression of imipemide (N-formimidoyl thienamycin) resistance in clinical isolates of coagulase-negative staphylococci. Antimicrob. Agents Chemother. 24:61-69.
9. Chambers, H. F., and C. J. Hackbarth. 1987. Effect of NaCl and nafcillin on penicillin-binding protein 2a and heterogeneous expression of methicillin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 31:1982-1988.
10. Climo, M. W., R. L. Patron, and G. L. Archer. 1999. Combinations of vancomycin and β-lactams are synergistic against staphylococci with reduced susceptibilities to vancomycin. Antimicrob. Agents Chemother. 43:1747-1753.
11. Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing; 15th informational supplement M100-S14. Clinical and Laboratory Standards Institute, Wayne, Pa.
12. Daum, R. S., S. Gupta, R. Sabbagh, and W. M. Milewski. 1992. Characterization of Staphylococcus aureus isolates with decreased susceptibility to vancomycin and teicoplanin: isolation and purification of a constitutively produced protein associated with decreased susceptibility. J. Infect. Dis. 166:1066-1072.
13. Debbia, E., P. E. Varaldo, and G. C. Schito. 1986. In vitro activity of imipenem against enterococci and staphylococci and evidence for high rates of synergism with teicoplanin, fosfomycin. and rifampin. Antimicrob. Agents Chemother. 30:813-815.
14. De Jonge, B. L. M., H. de Lencastre, and A. Tomasz. 1991. Suppression of autolysis and cell wall turnover in heterogeneous Tn551 mutants of a methicillin-resistant Staphylococcus aureus strain. J. Bacteriol. 173:1105-1110.
15. De Jonge, B. L. M., and A. Tomasz. 1993. Abnormal peptidoglycan produced in a methicillin-resistant strain of Staphylococcus haemolyticus grown in the presence of methicillin: functional role for penicillin-binding protein 2A in cell wall synthesis. Antimicrob. Agents Chemother. 37:342-346.
16. Domaracki, B. E., A. Evans, K. E. Preston, H. Fraimow, and R. A. Venezia. 1998. Increased oxacillin activity associated with glycopeptides in coagulase-negative staphylococci. Eur. J. Clin. Microbiol. Infect. Dis. 17:143-150.
17. Domaracki, B. E., A. M. Evans, and R. A. Venezia. 2000. Vancomycin and oxacillin synergy for methicillin-resistant staphylococci. Antimicrob. Agents Chemother. 44:1394-1396.
18. Domenech, A., S. Ribes, C. Cabellos, F. Taberner, F. Tubau, M. A. Domínguez, A. Montero, J. Liñares, J. Ariza, and F. Gudiol. 2005. Experimental study on the efficacy of combinations of glycopeptides and β-lactams against Staphylococcus aureus with reduced susceptibility to glycopeptides. J. Antimicrob. Chemother. 56:709-716.
19. Eliopoulos, G. M., and R. C. Moellering, Jr. 1996. Antimicrobial combinations, p. 330-396. In V. Lorian (ed.), Antibiotics in laboratory medicine, 4th ed. Williams & Wilkins, Baltimore, Md.
20. Froggatt, J. W., J. L. Johnston, D. W. Galetto, and G. L. Archer. 1989. Antimicrobial resistance in nosocomial isolates of Staphyhcoccus haemolyticus. Antimicrob. Agents Chemother. 33:460-466.
21. Goldstein, F. W., R. Atoui, A. Ben Ali, J. C. Nguyen, A. Ly, and M. D. Kitzis. 2004. False synergy between vancomycin and β-lactams against glycopeptide-intermediate Staphylococcus aureus (GISA) caused by inappropriate testing methods. Clin. Microbiol. Infect. 10:342-345.
22. Haraga, I., S. Nomura, and A. Nagayama. 1999. The effects of vancomycin and β-lactam antibiotics against vancomycin low-level or intermediately resistant Staphylococcus aureus. N. Engl. J. Med. 341:1624-1625.
23. Hiramatsu, K. 1998. Vancomycin resistance in staphylococci. Drug Resist. Updates 1:135-150.
24. Howe, R. A., M. Wootton, P. M. Bennett, A. P. MacGowan, and T. R. Walsh. 1999. Interactions between methicillin and vancomycin in methicillin-resistant Staphylococcus aureus strains displaying different phenotypes of vancomycin susceptibility. J. Clin. Microbiol. 37:3068-3071.
25. Linden, P. K. 1998. Clinical implications of nosocomial gram-positive bacteremia and superimposed antimicrobial resistance. Am. J. Med. 104(Suppl. 5A):24-33.
26. Livermore, D. M., and J. D. Williams. 1996. β-Lactams: mode of action and mechanisms of bacterial resistance, p. 502-578. In V. Lorian (ed.), Antibiotics in laboratory medicine, 4th ed. Williams & Wilkins, Baltimore, Md.
27. Martineau, F., F. J. Picard, L. Grenier, P. H. Roy, M. Ouellette, M. G. Bergeron, and the ESPRIT Trial. 2000. Multiplex PCR assays for the detection of clinically relevant antibiotic resistance genes in staphylococci isolated from patients infected after cardiac surgery. J. Antimicrob. Chemother. 46:527-533.
28. Matsuda, K., K. Nakamura, Y. Adachi, M. Inoue, and M. Kawakami. 1995. Autolysis of methicillin-resistant Staphylococcus aureus is involved in synergism between imipenem and cefotiam. Antimicrob. Agents Chemother. 39:2631-2634.
29. Schwalbe, R. S., W. J. Ritz, P. R. Verma, E. A. Barranco, and P. H. Gilligan. 1990. Selection for vancomycin resistance in clinical isolates of Staphylococcus haemofyticus. J. Infect. Dis. 161:45-51.
30. Schwalbe, R. S., J. T. Stapleton, and P. H. Gilligan. 1987. Vancomycin-resistant Staphylococcus. N. Engl. J. Med. 317:766-768.
31. Sieradzki, K., and A. Tomasz. 1997. Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus. J. Bacteriol. 179:2557-2566.
32. Sieradzki, K., P. Villari, and A. Tomasz. 1998. Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci. Antimicrob. Agents Chemother. 42:100-107.
33. Wong, S. S. Y., P. L. Ho, P. C. Y. Woo, and K. Y. Yuen. 1999. Bacteremia caused by staphylococci with inducible vancomycin heteroresistance. Clin. Infect. Dis. 29:760-767.